CMAB017

· Taizhou Mabtech Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMAB017, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of CMAB017 In Patients With Advanced Solid Tumors [Phase 1]